It has previously been suggested that polypharmacy originated because of a H • • • disappointment with currently available agents utilized singly for the control of psychiatric syndromes" (4 -p. 765) The pattern of adding additional psychoactive drugs to existing regimens developed from a failure of the original therapy to control behaviour adequately. Initially the use of combinations probably reflected the empirical attempts of clinicians to relieve treatment-resistant symptoms, rather than being a therapy form evolving from research data. However, exposure to its use during psychiatric residency training and current trends in the area of drug treatment procedures may have produced a climate wherein drug combinations are used early in the course of an illness rather than as a 'last resort'.
A number of studies concerned with polypharmacy as practised in continued treatment service wards have been conducted at the Central Islip State Hospital. One, a survey of the different treatment modalities employed in the hospital, revealed that approximately 28 per cent of all patients given psychopharmacological agents were receiving drug combinations (4) . Another study showed no significant differences in the residual symptom profiles of patients who were thought by their ward psychiatrists to be best suited to treatment with two major tranquillizers and those for whom a tranquillizer and an antidepressant were prescribed (3) . An investigation of the influence of polypharmacy upon hallucinatory behaviour found no significant posttreatment differences in this symptom between patients receiving one drug and a placebo, and patients treated with two active drugs (2) . Both the sex (4) and age (1) (1972) of the patients have also been shown to be related to patterns of treatment with drug combinations.
To date our studies have focused primarily upon the incidence and efficacy of polypharmacy as well as on symptom profiles associated with its use. The present study was undertaken in order to obtain data which would provide information as to the extent to which polypharmacy might be selected as the initial therapeutic modality in psychiatric disease with an acute onset, and also in order to compare single drug and multiple drug selecting respondents and the patient groups who were treated on a number of variables.
Method
A roster of psychiatrists practising in New York State Hospitals was derived from current staff listings supplied by the directors of each hospital. Each psychiatrist was sent a questionnaire designed to measure treatment preferences. Eight weeks later a follow-up questionnaire was mailed to nonrespondents. The first page of the questionnaire consisted of a short paragraph explaining the general nature of the research and a number of items designed to elicit information descriptive of the psychiatrists and the patients they treat. The second page presented a case history of an acute paranoid schizophrenic with a list of medications which could be used in treating the patient described in the paragraph. The third page was devoted to questions about the case. Respondents were asked to indicate which drug or drugs would be prescribed on the first day of hospitalization and at each of eight stages during the treatment of the case. The fourth page could be used for comments.
The returned questionnaires were separated into two major groups (single drug or polypharmacy) on the basis of the drug treatment regimen selected for the patient on the first day of hospitalization. When a SS-89 drug was used alone or with an antiparkinson agent it was considered to be a single drug program, while any combination of major tranquillizers, minor tranquillizers and energizers constituted polypharmacy. A total of three hundred and eight (45 per cent) of the six hundred and eightyseven psychiatrists polled returned questionnaires which could be sorted in this manner. Single drug treatment was selected by one hundred and eighty-two (59.1 per cent) of the respondents as their initial therapeutic procedure, with polypharmacy indicated by the remaining one hundred and twentysix (40.9 per cent) respondents. The tendency for this group to use polypharmacy exceeds by 13 per cent the frequency with which polypharmacy was found to be actually practised on a hospitalized, chronicallyill population.
Treatment combinations within the polypharmacy group were analysed, and statistical comparisons of the two groups were made of the psychiatrists' characteristics and their descriptions of the patients they treat. Table I summarizes the different drugs and drug combinations the respondents indicated as their preferred initial treatment regimen for the hypothetical patient.
Results and Discussion
From this table it can be seen that chlorpromazine (73.2 per cent) was the drug most often chosen by the single drug group and the chlorpromazine-trifluoperazine was the most frequently selected combination of drugs. Chlorpromazine was also combined with some other psychoactive agent by twelve (9.5 per cent) of the respondents. Therefore for this hypothetical patient, Significantly higher proportions of psychiatrists favouring polypharmacy were in practice for five or fewer years, had completed their residency within the last five years and had been trained in a hospital associated with a government agency. Significantly fewer drug combiners had present practice affiliations with a private or university-based hospital. No significant age, sex or type of practice differences were found. These data suggest that recency and source of training may be factors related to the tendency to prescribe multiple drug treatment. A cautious interpretation of these findings is that for this sample single/drug treatment seems slightly favoured by psychiatrists who completed their residencies prior to 1965 and had, or have, slightly more contact with psychiatry as practised in other than a government supported agency. Conversely, a greater tendency towards polypharmacy as an initial therapeutic regimen appears to be evident in psychiatrists trained recently in a non-government facility. Table III shows the percentage of patients the respondents described as falling into various sex, income, educational, age, marital status and type of disorder categories.
Both groups essentially perceive themselves as treating the same kinds of patients, as only one of twenty-four possible comparisons between the groups achieved statistical significance at the .05 level. Thus it does not appear likely that the preference for polypharmacy as opposed to single drug treatment is associated with experiences coming from characteristics of or kinds of patients seen by these psychiatrists.
Taken together, these data suggest for this sample that the tendency to employ drug combinations in treating a psychotic dysfunction may be mediated less by the presenting symptoms of the patient and practice-related experiences than by the source and recency of residency training and length of time in practice. Such a finding is consistent with the hypothesis that polypharmacy is currently 'in vogue' as a treatment regimen and is not entirely a practice employed as a last ditch effort to control symptoms and syndromes which do not yield to initial single drug procedures. The 41 per cent base rate incidence for Other 3 3 *t significant at .05 level.
drug combination usage as compared to a 29 per cent figure for usage on chronicallyill and hospitalized patients further supports this notion. Thus it appears that neither the lack of a clear cut rationale underlying the use of polypharmacy nor the paucity of controlled efficacy studies of this treatment regimen have mitigated the belief that 'two drugs are better than one' for a large proportion of the respondents.
Summary
A questionnaire which included a case history designed to elicit treatment preferences in psychiatric disease was distributed to psychiatrists on the staffs of seventeen state mental hospitals in New York State. Results of the survey, based upon a 45 per cent return, indicate that two of every five respondents selected polypharmacy as the preferred initial treatment regimen for the hypothetical patient described in the questionnaire. Recency of training (residency completion) and fewer private agency affiliations appeared to be the major characteristic of the psychiatrists in this sample, who tended to employ drug combinations. These data are interpreted as being consistent with the hypothesis that polypharmacy may currently be 'in vogue' as a therapeutic modality despite the lack of a clear cut rationale for its use or proof of its efficacy.
